Tadakazu Hisamatsu

65PUBLICATIONS
202CO-AUTHORS
Medical mycologyForest health and pathologyHorticultural crop improvement (incl. selection and breeding)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Jun 17, 2026
Histologic and combined histologic-endoscopic outcomes with mirikizumab in Crohn's disease: VIVID-1 trial results.

|May 01, 2026
Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial.

|May 01, 2026
Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week 92 of the QUASAR Long-Term Extension Study.

|Mar 16, 2026
Transabdominal intestinal ultrasound versus transmural histopathological findings in severe ulcerative colitis requiring colectomy.

Hiromu Morikubo, Jun Miyoshi, Akimasa Hayashi

|Jan 22, 2026
Clinical Significance of Endoscopic Improvement at 6 Months in Patients With Ulcerative Colitis Treated With Ustekinumab: A Retrospective Real-world Analysis.

Hiromu Morikubo, Minoru Matsuura, Haruka Komatsu

|Jan 19, 2026
Comparative Efficacy and Safety of Advanced Therapies in Maintenance Treatment of Adult Patients with Moderate-to-Severe Crohn's Disease: A Systematic Literature Review and Network Meta-Analysis.

Stefan Schreiber, Silvio Danese, Jean-Frédéric Colombel

Pageof 11

Frequent Collaborators

8 joint publications

Taku Kobayashi

7 joint publications

Katsuyoshi Matsuoka

5 joint publications

Remo Panaccione

5 joint publications

Toshifumi Hibi